Effect of Tamsulosin on the Patients with Lower Ureteral Stones after Extracorporeal Shock Wave Lithotripsy and Serum Levels of IL-6, IL-10 and CRP

Wen-tao WANG,Bai-lu JIAN,Shao-yi QIAO,Jin-tao JI,Lei WANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2018.21.021
2018-01-01
Abstract:Objective:To explore the clinical effect of tamsulosin on the extracorporeal shock wave lithotripsy (ESWL) of patients with ureteral calculi and the serum levels of interleukin-6 (IL-6), interleukin-10 (IL-10) and C-reactive protein (CRP).Methods:122 cases with lower ureteral stones who were treated in our hospital from January 2015 to December 2016 were selected and randomly divide into two groups.After ESWL, the patients in the control group were treated with nifedipine, while the patients in the observation group were treated with tamsulosin.Then the postoperative row of stones, the pain, the serum levels of IL-6, IL-10 and CRP and the incidence of adverse reactions in the two groups before and after the treatment.Results:After treatment, the stone free rate of the observation group was91.8%, which was significant higher than 78.7%in the control group (P<0.05).The time of row stone and the diameter of stone row in the observation group were significantly better than those of the control group (P<0.05).The incidence of renal colic, analgesic use and VAS score in the observation group were significantly lower than those of the control group (P<0.01).The serum inflammatory cytokine levels in the observation group were significantly lower than those of the control group (P<0.01).There was no statistically significant difference about the incidence of adverse reactions between the two groups (P>0.05).Conclusion:Tamsulosin could improve the row stone effectively for patients with lower ureteral stones after ESWL, reduce the operation injury and relieve the postoperative pain.
What problem does this paper attempt to address?